Get startedLog in
    Picture of Burning Rock Biotech logo

    BNR — Burning Rock Biotech Cashflow Statement

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousMicro CapNeutral
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Burning Rock Biotech, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

    2020
    December 31st
    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:20-F20-F20-F20-F6-K
    Standards:
    USG
    USG
    USG
    USG    		—
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line-407-797-971-654—
    Depreciation
    Amortisation
    Non-Cash Items185333401317—
    Unusual Items
    Equity in Net Earnings/Losses
    Other Non-Cash Items
    Changes in Working Capital116-62.4-11.2-52.2-92.3
    Change in Accounts Receivable
    Change in Inventories
    Change in Prepaid Expenses
    Change in Other Assets
    Change in Accounts Payable
    Change in Accrued Expenses
    Change in Other Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities-73.5-478-457-256-92.3
    Capital Expenditures-79.5-213-75.5-9.38—
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items-29.8295680.084-4.41
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities-10981.7-7.46-9.3-4.41
    Financing Cash Flow Items0.701-3.82-12-41.9-0.072
    Other Financing Cash Flow
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities2,166-52.9-86.2-48.8-0.072
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash1,827-486-514-310-93.1